Exclusive Licensing Gives Biologics CROs Major Advantage
FN Media Group Presents Microsmallcap.com Market Commentary New York, NY – April 26, 2019 – Biopharma companies rise and fall on the back of research and development. Success in the biopharma industry has always been about patents. The exclusive right to market life-saving treatments is how all the industry titans made their names. Johnson […]
Monoclonal Antibody Therapy Drug Market on Trajectory Towards $140 Billion
New York, NY – April 4, 2019 – Timelines on the next generation of antibody discovery may be getting shorter. Potentially incentivized by a new study on the monoclonal antibody therapy market, analysts recently projected a double-digit 10.5% CAGR by 2022, and revenues to touch $140 billion. Driving this surge is the development of new […]
ImmunoPrecise Launches DeepDisplay(™) Antibody Discovery Platform
ImmunoPrecise Launches Large-Scale Discovery Program with US Pharma Company Victoria, BC – April 2, 2019 – IMMUNOPRECISE ANTIBODIES LTD. (the “Company” or “IPA”) (TSX VENTURE: IPA) (OTC PINK: IPATF) announces the expansion of their service offerings in therapeutic antibody discovery to select rare, fully human antibodies using DeepDisplayTM, a combination of transgenic animal immunization […]
